Related Experiment Videos
Influenza vaccination in elderly people
1Section of Gerontology and Geriatrics, Leiden University Medical Centre, The Netherlands. E.Remarque@Thuisnet.LeidenUniv.NL
Experimental Gerontology
|August 5, 1999
Summary
Influenza vaccination effectiveness is reduced in older adults. This review explores factors like health status and prior infections that impact elderly antibody responses to vaccines and discusses potential improvements.
Area of Science:
- Gerontology
- Immunology
- Vaccinology
Background:
- Influenza poses significant morbidity and mortality risks for the elderly population.
- While influenza vaccines reduce hospitalizations and deaths, antibody induction can be suboptimal in older adults.
- Factors influencing vaccine efficacy in the elderly require further investigation.
Purpose of the Study:
- To discuss factors contributing to the reduced serological efficacy of influenza vaccines in the elderly.
- To explore potential strategies for enhancing antibody responses to influenza vaccination in this demographic.
Main Methods:
- Literature review and synthesis of existing research on influenza vaccine immunogenicity in older adults.
- Analysis of factors influencing immune response, including health status and prior influenza virus exposure.
- Discussion of emerging approaches to improve vaccine effectiveness.
Main Results:
- Elderly individuals exhibit variable antibody induction following influenza vaccination.
- Health status and previous influenza virus exposures are identified as key factors influencing immune response.
- Specific interventions may improve antibody generation in response to vaccination.
Conclusions:
- Suboptimal antibody responses to influenza vaccines in the elderly are multifactorial.
- Addressing factors like health status and prior exposures is crucial for improving vaccine efficacy.
- Further research into novel vaccination strategies is warranted to enhance protection in older adults.